(Q53029146)

10 May 2018

title

Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. (English)

1 reference

10 May 2018

Jae Huh

6

0 references

Dennis Chi

1

Dennis S Chi

1 reference

10 May 2018

Richard R Barakat

8

Richard R Barakat

1 reference

10 May 2018

Yukio Sonoda

3

Yukio Sonoda

1 reference

10 May 2018

Nadeem R. Abu-Rustum

4

Nadeem R Abu-Rustum

1 reference

10 May 2018

Michael W Kattan

9

Michael W Kattan

1 reference

10 May 2018

Christopher S Awtrey

5

Christopher S Awtrey

1 reference

10 May 2018

Eric L Eisenhauer

7

Eric L Eisenhauer

1 reference

10 May 2018

Meena J Palayekar

2

Meena J Palayekar

1 reference

10 May 2018

language of work or name

English

0 references

publication date

24 October 2007

1 reference

10 May 2018

published in

Gynecologic Oncology

1 reference

10 May 2018

volume

108

1 reference

10 May 2018

issue

1

1 reference

10 May 2018

page(s)

191-194

1 reference

10 May 2018

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Identification of prognostic factors in advanced epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Postoperative Nomogram for 12-Year Sarcoma-Specific Death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

A prognostic model for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Predictability of the survival of patients with advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.020

10.1016/J.YGYNO.2007.09.020

7 January 2021

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018